Cascades Inc. (CAS) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cascades Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.156 1.9%, slightly below the industry's comparable of 1.6% decrease. 00:00:06.698 -- 00:00:11.664 Just a little bit, they also decreased 6% year-over-year for the same reason I just explained. 00:00:11.664 -- 00:00:17.669 These impacts more than offset selling price and raw material costs tailwinds. 00:00:18.011 -- 00:00:23.297 Moving now to our tissue segment. Sales decreased by 7% sequentially, reflecting 00:00:23.297 -- 00:00:25.099 usual seasonality. 00:00:25.099 -- 00:00:30.180 To this end, sequential shipments in the away-from-home market decreased 10%, while 00:00:30.180 -- 00:00:35.406 retail shipments decreased by 3%. I just said a bid of $33 million decreased 21% 00:00:35.406 -- 00:00:37.348 sequentially. 00:00:37.348 -- 00:00:41.733 This level was slightly below forecast due to higher operating costs following important 00:00:41.733 -- 00:00:46.618 cost pressure, most notably coming from transportation and fuel. 00:00:46.618 -- 00:00:50.222 Lower volumes were expected due to usual seasonality. 00:00:50.222 -- 00:00:55.248 These impacts were partially offset by benefits from lower raw material costs and higher 00:00:55.248 -- 00:00:57.370 selling prices. 00:00:57.370 -- 00:01:02.531 Over-year sales increased 4%. This was driven by an 11% increase 00:01:02.531 -- 00:01:08.057 in retail product shipments and a 6% increase in shipments of away-from-home, underscoring 00:01:08.057 -- 00:01:11.922 the growing traction of our commercial initiatives. 00:01:11.922 -- 00:01:17.188 Adjusted EBITDA decreased 11% from last year, with benefits from raw material costs, 00:01:17.188 -- 00:01:22.273 volume, and higher selling prices more than offset by operating costs and wins. 00:01:22.273 -- 00:01:27.119 I'll now pass the call to Alan, who...